Revance Therapeutics, Inc.
Q4 2021 Earnings Call Transcript

Published:

  • Disclaimer*:
    This transcript is designed to be used alongside the freely available audio recording on this page. Timestamps within the transcript are designed to help you navigate the audio should the corresponding text be unclear. The machine-assisted output provided is partly edited and is designed as a guide.
  • Operator:
    0
  • Jessica Serra:
    0
  • Mark Foley:
    2
  • Dustin Sjuts:
    9
  • Toby Schilke:
    12
  • Mark Foley:
    16
  • Operator:
    17
  • Ken Cacciatore:
    17
  • Mark Foley:
    18
  • Ken Cacciatore:
    19
  • Mark Foley:
    19
  • Operator:
    19
  • Unidentified Analyst:
    19
  • Toby Schilke:
    20
  • Unidentified Analyst:
    20
  • Toby Schilke:
    20
  • Operator:
    20
  • David Amsellem:
    20
  • Mark Foley:
    21
  • Dustin Sjuts:
    21
  • Mark Foley:
    23
  • David Amsellem:
    24
  • Mark Foley:
    24
  • Operator:
    24
  • Annabel Samimy:
    24
  • Mark Foley:
    25
  • Annabel Samimy:
    27
  • Operator:
    27
  • Balaji Prasad:
    27
  • Mark Foley:
    28
  • Toby Schilke:
    29
  • Balaji Prasad:
    30
  • Mark Foley:
    30
  • Operator:
    30
  • Tim Lugo:
    30
  • Dustin Sjuts:
    31
  • Tim Lugo:
    32
  • Mark Foley:
    32
  • Tim Lugo:
    33
  • Operator:
    33
  • Douglas Tsao:
    33
  • Mark Foley:
    33
  • Douglas Tsao:
    34
  • Operator:
    34
  • Unidentified Analyst:
    34
  • Dustin Sjuts:
    34
  • Unidentified Analyst:
    35
  • Operator:
    35
  • Mark Foley:
    35
  • Operator:
    36

Other Revance Therapeutics, Inc. earnings call transcripts: